Oral liquid compositions including valsartan
US10548838B1 · kind B1 · utility
3Cited by
1References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 14, 2018 |
| Grant date | Feb 4, 2020 |
| Priority date | — |
| Expiry date | Dec 14, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61J1/05
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides an oral liquid composition comprising valsartan with enhanced solubility and stability. Also, provided herein are methods of using the oral liquid compositions for the treatment of hypertension, treatment of heart failure and reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.